Abiopharma

Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference

New Form 8-K - MoonLake Immunotherapeutics Filed: 2025-08-05 AccNo: 0001821586-25-000016 Size: 285 KB Item 2.02: Results of Operations and Financial Condition

Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

ImmunityBio Reports Q2 Earnings Release Reflecting 60% Increase in Revenue in Q2 2025, With Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-code

Beam Therapeutics Reports Second Quarter 2025 Financial Results and Provides Update on BEAM-302 Development Progress in Alpha-1 Antitrypsin Deficiency (AATD)

Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings

New Form 10-Q - Pediatrix Medical Group, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102382 Size: 6 MB

Enanta Pharmaceuticals to Participate in the H.C. Wainwright & Co.“HCW@Home” Series

Zoetis - Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook

Axogen, Inc. Reports Second Quarter 2025 Financial Results

New Form 6-K - AC Immune SA Filed: 2025-08-05 AccNo: 0001558370-25-010174 Size: 5 MB

AdaptHealth Corp. Announces Second Quarter 2025 Results

Orthofix Medical Inc. - Orthofix Reports Second Quarter 2025 Financial Results

ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine